A Randomized, Controlled Study on the Efficacy and Safety of Hetrombopag in the Treatment of Chemotherapy-induced Thrombocytopenia(CIT) in Patients With Acute Myeloid Leukemia
Latest Information Update: 20 Sep 2024
At a glance
- Drugs Hetrombopag (Primary)
- Indications Chemotherapy-induced damage; Thrombocytopenia
- Focus Therapeutic Use
- Acronyms H-CIT-AML
- 17 Jul 2023 New trial record